Viruses isolated from the blood of two Korean haemorrhagic fever patients were propagated in cell culture and compared to prototype Hantaan virus which was isolated from Apodemus mice. The antigenic properties of the human isolates were found to be closely related to Hantaan virus by plaque reduction neutralization, haemagglutination inhibition and fluorescent antibody staining with both polyclonal and monoclonal antibodies. The medium genome segment of each human isolate was sequenced and compared to that of Hantaan virus. Nucleotides comprising the Hantaan virus G 1 and G2 envelope protein-coding regions differed from those of the other viruses by only 5.4~o and 5-7~o. The human isolates differed from one another by 1.6~. The nucleotide differences resulted in predicted amino acid variations of 1.3~ to 2-3~ among the three viruses, with the majority occurring as conservative substitutions in G1.
INTRODUCTION
Korean haemorrhagic fever (KHF) was first recognized by western physicians as a serious disease threat in 1951, when more than 2400 United Nations troops stationed in Korea developed illness characterized by fever, headache, back and abdominal pain and various haemorrhagic manifestations (Lee, 1982a) . Although KHF was previously unreported in Korea, similar diseases had been recognized for many years throughout Asia (Lee, 1982b) . A viral aetiology for the disease was long suspected, but conclusive demonstration of such an agent did not occur until 1976, when antigen reactive with convalescent patient sera was discovered in lung tissues from Korean field mice (Apodemus agrarius) (Lee et at., 1978) , and after several successive passages in seronegative Apodemus, a virus, KHF strain 76-118, was isolated. Conditions for its cell culture propagation were subsequently determined , and the virus was renamed Hantaan after a Korean river in the endemic region where the first infected Apodemus were trapped (Lee, 1982b) .
Hantaan and serologically related viruses constitute the newly established Hantavirus genus of Bunyaviridae. Viruses in this genus have been associated with numerous clinically similar diseases collectively termed haemorrhagic fever with renal syndrome (HFRS) (WHO, 1982) . All hantaviruses currently recognized cause inapparent infections of their rodent hosts and are believed to be transmitted to humans primarily through aerosol exposure to virus contained in the animals' urine, faeces and saliva. The absence of a good animal model of HFRS has precluded demonstration of a cause and effect relationship of Hantaan virus infection with KHF. Recent isolations of viruses from HFRS patients, however, have afforded the opportunity to compare and contrast a virus 0000-8304 © 1988 SGM isolated from a natural rodent host to those associated with clinical disease in humans. These data provide important and useful insights into the antigenic and genetic stability of the virus over time, and confirm the aetiological role of Hantaan virus in KHF.
METHODS

Viruses and cells.
The isolation and cell culture adaptation of Hantaan virus (76-118) has been described (Lee et al., 1978 . Propagation and assay of Hantaan virus in Vero E6 cells (ATCC C1008) was as previously reported (Schmaljohn et al., 1983) .
The Lee isolate (77-137) was obtained by inoculation of viraemic blood from a KHF patient into seronegative A. agrarius (Lee et al., 1981 b) . After three Apodemus passages, lung and kidney specimens were homogenized and incubated with A549 (ATCC CCL185) cells. Cultures were monitored for the presence of viral antigen by indirect immunofluorescence and, after several blind passages, the isolate could be readily propagated in cell culture. Because the virus inoculum was contaminated with reovirus, the Lee isolate was passaged four times in Vero E6 cells in the presence of reovirus antisera (types 1, 2 and 3). Two additional passages without reovirus antisera were performed, and the absence of extraneous viruses and mycoplasma was confirmed by both culture and electron microscopic examination.
The HoJo isolate (ROK 83-61) was obtained without prior passage in Apodemus by inoculation of Vero E6 cell cultures with viraemic blood from a KHF patient. Cell cultures were incubated at 37 °C for 14 days, after which cells were examined for the presence of viral antigen by indirect immunofluorescence. Samples found to contain viral antigen were cocultivated with an equal number of uninfected Vero E6 cells and incubated at 37 °C for 14 days. Cocultivation was repeated twice more at 14 day intervals, and the final cell supernatant was assayed for infectious virus by plaque formation on Vero E6 cells.
Immune animal sera. The preparation of hantavirus-immune sera in experimentally infected rats has been described (Schmaljohn et al., 1985) . Immune rabbit sera were generated by a single intramuscular inoculation of at least two New Zealand white rabbits, each with infectious, cell culture-propagated Hantaan, Puumala, Prospect Hill or Seoul urban rat viruses. Rabbit sera were tested at weekly intervals for the presence of virus-neutralizing antibody, and high-titre sera were pooled as reference antisera for each of the four viruses. One of the monoclonal antibodies (MAbs) used in these studies (HCO2) was obtained from Dr J. McCormick (Centers for Disease Control, Atlanta, Ga., U.S.A.). Hybridomas were prepared using the spleens of mice immunized with inactivated Hantaan virus (J. McCormick, personal communication). For production of additional MAbs, 6-to 8-week-old, female BALB/c mice were immunized intramuscularly with preparations of Hantaan virus envelope glycoproteins in Freund's complete adjuvant. Twenty days later, the same antigen in Freund's incomplete adjuvant was administered intramuscularly. The final immunization consisted of an intraperitoneal injection of the same antigen without adjuvant 18 days after the second immunization. Four days later, spleens were harvested and cells were fused to SP2/0-Ag-14 partners according to standard procedures (Early & Osterling, 1985) . Ascitic fluids were prepared according to the method of Brodeur et al. (1984) . Antibody specificity was determined by immunoprecipitation of radiolabelled viral proteins as previously described (Schmaljohn et aL, 1986) . Plaque reduction neutralization reaction conditions have been described (Schmaljohn et al., 1985) .
Sequence analysis. Oligonucleotides corresponding to the following nucleotides with respect to 5' viral complementary sense RNA of Hantaan virus were synthesized on an Applied Biosystems model 541 DNA synthesizer: 23 to 42, 101 to 120, 223 to 242, 318 to 337, 494 to 513,535 to 554, 576 to 595, 611 to 630, 732 to 751,805 to 824, 1079 to 1099, 1113 to 1132, 1253 to 1273, 1395 to 1414, 1502 to 1522, 1689 to 1708, 1698 to 1716,1931 to 1950, 2067 to 2086, 2216 to 2235, 2501 to 2520, 2629 to 2647, 2764 to 2783, 3056 to 3075, 3070 to 3088, 3161 to 3180, 3258 to 3277 and 3375 to 3394. Additional primers required to read ambiguous sequences were prepared with sequence data determined for HoJo. The primers were annealed to purified virion RNA and dideoxynucleotide chain termination sequence reactions were performed essentially as described (Seif et al., 1985) . Briefly, 5 to 10 ~tg of RNA and 0.5 ~tg of oligonucleotide primer were denatured with 50 mM-methylmercuric hydroxide at room temperature for 10 min in a reaction volume of l0 ~tl. Two ~tl of 350 mM-2-mercaptoethanol was added and incubation continued for 5 to 10 min. The RNA-primer solution was then added to a reaction mixture containing 4 ktl 1 M-Tris-HCl pH 8-3, 6 ~tl 1 M-KCI, 2 ~tl 0.2 M-MgCI2, 2 ~tl each of 1 mM-dATP, dCTP, dGTP and dTTP, 4 lal [ct-32P]dATP (3000 Ci/mmol; Amersham) and 2 to 3 p.l avian myeloblastosis virus reverse transcriptase (Life Sciences, St Petersburg, Fla., U.S.A.). Nine ~tl of this reaction mixture was added to each of four tubes containing 2 ~l 50 ~t~l-dideoxy ATP, GTP, CTP or TTP, and tubes were incubated at 43 °C for t5 rain. Reactions were terminated by the addition of 5 p.l of loading buffer (95 ~ formamide, 10 mM-EDTA). Samples were boiled for 3 min prior to gel electrophoresis.
RESULTS
Serological comparisons
At least four antigenic groups of hantaviruses can be differentiated by plaque reduction neutralization tests (PRNT) (Schmaljohn et al., 1985) . Immune sera to viruses representative of * Rabbit and rat sera from experimentally infected animals and human sera from a KHF patient or from a subclinical laboratory infection with Hantaan virus were reacted with each virus as described in Methods. Titres are the reciprocal of the dilution resulting in greater than 80~ reduction in viral plaques.
t Homologous titres for Prospect Hill, Puumala and Seoul viruses were 2560, 1280 and 5120, respectively. :~ Mouse monoclonal ascitic fluid was prepared with each of the indicated hybridomas and reacted with viruses as described in Methods.
each group (Hantaan, Prospect Hill, Puumala and Seoul) were used in a PRNT to compare two viruses, HoJo and Lee which were isolated from KHF patients, with prototype Hantaan virus. Immune animal sera were prepared by experimental infection of rabbits or rats as described in Methods. Human sera were obtained from a convalescent KHF patient and from a laboratory worker asymptomatically infected with Hantaan virus. None of the sera produced more than twofold differences in neutralization titres with the three viruses ( Table 1) . As previously demonstrated with rat immune sera (Schmaljohn et al., 1985) , rabbit sera to Puumala virus, the aetiological agent of nephropathia epidemica, had a very low neutralizing titre with Hantaan virus and, similarly, poorly neutralized HoJo and Lee. Immune rabbit sera generated to Seoul virus produced low PRNT titres with Hantaan virus, despite a high (1:5120) homologous neutralization titre; rabbit sera generated to Prospect Hill virus produced PRNT titres with Hantaan virus equivalent to the homologous titre. Therefore, each serum examined produced consistent PRNT titres with Hantaan, HoJo and Lee viruses, and failed to distinguish between them.
Plaque reduction by six Hantaan virus-specific, neutralizing MAbs also failed to differentiate prototype Hantaan from HoJo and Lee viruses. Three G2-specific and three Gl-specific Hantaan MAbs produced PRNT titres with HoJo and Lee viruses that did not differ by more than twofold from those obtained with Hantaan virus (Table 1) T  1174  451  C  T  T  1180  460  A  A  T  1192  493  C  T  C  1210  496  T  C  T  1245  544  G  A  A  1246  558  G  C*  C*  1267  559  T  C*  C*  1309  562  C  T  T  1324  565  T  C  C  1325  580  G  A  G  1333  589  G  A  A  1348  595  C  T  T  1357  610  A  G  G  1369  619  C  T  T  1379  631  G  A  G  1393  640  C  C  T  1402  649  T  C  C  1420  667  A  G  G  1429  670  T  C  C  1444  679  T  C  C  1456  766  A  G  A  1460  769  A  T  G  1474  778  T  C  C  1519  850  T  C  C 846  109  V  I  I  1027  156  S  T  T  1036  272  I  T~  T~  1037  274  S  T  T  1055 
G2 amino acids Hantaan HoJo Lee
* Amino acids are numbered from the amino-terminal amino acid of Hantaan virus GI (Schmaljohn et al., 1987) . t X indicates a deleted amino acid. :~ Non-conservative amino acid differences from Hantaan virus according to the following criteria for conservative substitutions: R=K, S=T, D=E, Q=N, V=L=I=M, A=G, A=V, Y=F.
virion RNA templates. With respect to the coding region for Hantaan virus G1 and G2 (nucleotides 92 to 3445), 180 nucleotide differences (5.4~) in in HoJo virus were detected ( Table 2 ). The majority of the nucleotide differences were silent substitutions, i.e. only 31 HoJo virus nucleotides (0-9~) and 21 contributed to changes in the predicted amino acid sequence of the polyprotein encoded in Hantaan virus M RNA. Many of the nucleotide variations observed were common to HoJo and Lee viruses, which had 53 nucleotide differences (1.6~) from each other, of which 15 (0.4~) contributed to predicted amino acid differences.
In addition to individual nucleotide variations, sequence analysis of the G2-coding region of HoJo virus revealed the deletion of three bases (one codon) at nucleotide positions 2126 to 2128.
Comparison of the predicted amino acids comprising G1 and G2 of Hantaan, HoJo and Lee viruses
Comparison of the predicted amino acid sequences of the envelope proteins of the three viruses revealed differences with respect to Hantaan virus of 20 (1"7~o) and 27 amino acids (2.3 %) for Lee and HoJo viruses respectively (Table 3 ). The two human isolates shared all but 15 (1.3 %) of their predicted G 1 and G2 amino acids. None of the amino acid differences occurred at any of the potential seven asparagine-linked glycosylation sites or at the amino or carboxy termini of G1 or G2 (Schmaljohn et al., 1987) . Of the amino acids that differed among the isolates, most were conservative variations with less than t % of the total amino acids appearing as non-conservative differences. Although more amino acid differences were observed in the predicted G1 proteins than in the G2 proteins of these viruses, the proportion of nonconservative changes was almost the same (0.4 to 0.9%). Consequently, hydropathicity profiles of both of the M segment gene products of the three viruses were nearly indistinguishable (not shown).
DISCUSSION
We have compared the antigenic properties and gene sequences of two virus isolates from acutely infected KHF patients to those of prototype Hantaan virus which was originally isolated from Apodemus. These studies were intended (i) to confirm the aetiology of KHF, (ii) to delineate antigenic and genetic variations of viruses isolated at different times from a persistently infected natural host compared to isolates from an acutely infected dead-end host and (iii) to gain insight into the advisability of using prototype Hantaan virus strain 76--118 for the development of an HFRS vaccine.
Antigenic comparisons by haemagglutination inhibition, immunofluorescence and PRNT revealed little difference between the two human isolates and Hantaan virus. Epitope variation was suggested only by the reduced reactivity of a single Hantaan virus-specific, anti-G2 MAb with HoJo and Lee viruses. This MAb did not neutralize any of the three viruses; the significance of this is currently not known. None of the immune sera or MAbs used in these comparisons distinguished HoJo virus from Lee virus.
Sequence analysis of the viral M genome segments confirmed the similarity of Hantaan, HoJo and Lee viruses and suggested a remarkable conservation of their envelope glycoproteins. These data suggest stability of the genes encoding the viral proteins that are most likely to encounter natural immune modulation and selection, i.e. the viral envelope proteins. This stability, not only in dissimilarly affected hosts (acute or persistent infection) but also over time (6 years), may indicate an absence of immunological pressures that would cause viral mutation or, conversely, pressures which continually select for a certain virus population and prevent the emergence of variants. It has been shown that, although experimentally infected Apodemus produce Hantaan virus-neutralizing antibodies, infectious virus continues to be excreted in the animals' urine, faeces and saliva for at least l year after infection, with no apparent deleterious effect on the rodents (Lee et al., 1981 a, b) . It is not known at present how the virus escapes neutralization, or even whether neutralization is the primary mode of recovery from virus infection. Whatever selective pressures exist in nature, it is clear from our studies that the Apodemus isolate, Hantaan virus, and the two isolates from KHF patients are nearly identical, and perhaps should be considered strains of the same virus.
Our results suggest that a vaccine developed to Hantaan virus, whether by classical methods or recombinant DNA technology, should be equally reactive with viruses known to cause KHF. Ideally, a vaccine targeted at KHF should also be able to protect against other HFRS illnesses. With the information currently available, it is impossible to predict the success of such a vaccine with HFRS in general. Studies similar to those described here, with viruses in the other three hantavirus antigenic groups, would help to define conserved gene regions among all hantaviruses, thus enabling the development of vaccines or diagnostic reagents which are crossreactive among many different hantaviruses.
